The FDA has issued an alert that repackaged intravitreal injections of the drug Avastin have caused at least a dozen serious eye infections in the Miami area, according to an FDA news release. The ...

The Department of Veterans Affairs said it has stopped using the drug Avastin to treat eye disease, as it investigates concerns about serious infections and blindness from the drug, according to a ...

LOS ANGELES, Nov 28 (Reuters) - A U.S. Senator said on Wednesday he is investigating Genentech Inc's plan to stop supplying its cancer drug Avastin to pharmacies that divide vials of the medicine so ...

Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. Outlook Therapeutics has been trying to get an official approval for a reformulated ...

Due to a shortage of a widely used compounded medicine for serious eye diseases, two leading ophthalmologic groups want Medicare contractors to halt practices that limit coverage of other — albeit ...

LONDON, June 11 (Reuters) - Roche's cancer drug Avastin is a cheap, effective treatment for preventing blindness and should be used routinely in countries that cannot afford the far more costly ...

One option for macular degeneration cuts treatment costs from $2,000 to $50. April 4, 2011— -- One drug costs $50 per dose. The other costs $2,000 per dose. Now, new research shows that the drug ...

Dear Dr. Roach: I was diagnosed with stage 1 bladder cancer in April. My urologist advised me to have BCG therapy for it. I just completed six weeks of the therapy. I also have macular degeneration in ...

The results are expected to lead many doctors and patients to turn away from the pricier Lucentis and instead use $50 shots of Avastin for an age-related condition called wet macular degeneration.

In the wake of the US Food and Drug Administration’s decision to revoke approval of Avastin for the treatment of metastatic breast cancer, drug maker Genentech says it will conduct a new clinical ...